Clinical Research Directory
Browse clinical research sites, groups, and studies.
REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam
Sponsor: Arsenal Medical, Inc.
Summary
The purpose of this study is to demonstrate safety, effectiveness and benefit-risk profile of ResQFoam for the inhospital treatment of exsanguinating, intraabdominal haemorrhage due to trauma in patients where emergent laparotomy is required.
Official title: Reducing Exsanguination Via In-Vivo Expandable Foam
Key Details
Gender
All
Age Range
15 Years - Any
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2025-08-07
Completion Date
2026-12-31
Last Updated
2025-11-10
Healthy Volunteers
No
Interventions
ResQFoam
Hemostatic device for the treatment of emergent, exsanguinating, Class III or IV intraabdominal hemorrhagic shock in subjects due to trauma
Locations (2)
University of Alabama at Birmingham
Birmingham, Alabama, United States
University of Cincinnati
Cincinnati, Ohio, United States